Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 5, 2012, Pages 778-785

  Ansaloni, Luca ^a   Agnoletti, Vanni ^b   Amadori, Andrea ^c   Catena, Fausto ^d   Cavaliere, Davide ^e   Coccolini, Federico ^a   De Iaco, Pierandrea ^d   Di Battista, Monica ^e   Framarini, Massimo ^e   Gazzotti, Filippo ^d   Ghermandi, Claudio ^e   Kopf, Barbara ^e   Saponara, Maristella ^f   Tauceri, Francesca ^e   Vallicelli, Carlo ^d   Verdecchia, Giorgio Maria ^e   Pinna, Antonio Daniele ^d  

^a OSPEDALI RIUNITI   (Italy)

^b Unit of Anaesthesiology   (Italy)

^c Unit of Gynecology and Obstetrics   (Italy)

^d MORGAGNI PIERANTONI HOSPITAL   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

Cytoreductive surgery; Intraperitoneal chemotherapy; Ovarian cancer; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; DOXORUBICIN; PACLITAXEL;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLON ISCHEMIA; CYSTOVAGINAL FISTULA; CYTOREDUCTIVE SURGERY; DIGESTIVE TRACT PARAMETERS; FEASIBILITY STUDY; FEMALE; HOSPITALIZATION; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; INTRA ABDOMINAL HEMORRHAGE; INTRAABDOMINAL OUTFLOW TEMPERATURE; INTRAOPERATIVE PERIOD; LENGTH OF STAY; LUNG EMBOLISM; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; ONCOLOGICAL PARAMETERS; OPEN STUDY; OVARY CARCINOMA; PELVIS ABSCESS; PERITONEAL CANCER INDEX; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; SURGICAL MORTALITY; TEMPERATURE; TUMOR VOLUME; WOUND DEHISCENCE;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; DOXORUBICIN; ENDOMETRIAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84863635796     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31824d836c     Document Type: Article

References (30)

1. Bonnefoi H, A'Hern RP, Fisher C, et al. Natural history of stage IV epithelial ovarian cancer. J Clin Oncol. 1999;17:767-775. (Pubitemid 29109304)
2. Yancik R. Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer. 1993;71:517-523. (Pubitemid 23021245)
3. Abu-Rustum NR, Chi DS, Curtin JP. Epithelial ovarian cancer. Curr Probl Surg. 1999;36:7-53.
4. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;5:1248-1259. (Pubitemid 34177431)
5. Elit L, Oliver TK, Covens A, et al. Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with meta-analyses. Cancer. 2007;109:692-702. (Pubitemid 46233230)
6. Armstrong DK, Bundy B, Wenzel L, et al; Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006; 354:34-43. (Pubitemid 43048949)
7. Trimble EL, Alvarez RD. Intraperitoneal chemotherapy and the NCI clinical announcement. Gynecol Oncol. 2006;103:S18-S19. (Pubitemid 44633412)
8. Martin LP, Schilder RJ. Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol. 2009;36:112-125.
9. Leitao MM Jr, Chi DS. Surgical management of recurrent ovarian cancer. Semin Oncol. 2009;36:106-111.
10. Bristow RE, Puri I, Chi DS. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol. 2009;112:265-274.
11. Kecmanovic DM, Pavlov MJ, Kovacevic PA, et al. Cytoreductive surgery for ovarian cancer. Eur J Surg Oncol. 2003;29:315-320. (Pubitemid 36675685)
12. Deraco M, Rossi CR, Pennacchioli E, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori. 2001;87:120-126. (Pubitemid 32660378)
13. Look M, Chang D, Sugarbaker PH. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer. 2003;13:764-770. (Pubitemid 38235220)
14. Helm CW, Randall-Whitis L, Martin RS III, et al. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol. 2007;105:90-96. (Pubitemid 46441446)
15. Cotte E, Glehen O, Mohammed F, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients. World J Surg. 2007;31:1813-1820. (Pubitemid 47283201)
16. Gori J, Castanõ R, Toziano M, et al. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer. 2005;15:233-239. (Pubitemid 40396958)
17. Chua TC, Robertson G, Liauw W, et al. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol. 2009;135:1637-1645.
18. Roviello F, Pinto E, Corso G, et al. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol. 2010;102:663-670.
19. Los G, Smals OA, van Vugt MJ, et al. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res. 1992;52: 1252-1258.
20. Meyn RE, Corry PM, Fletcher SE, et al. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminechloroplatinum(II). Cancer Res. 1980;40: 1136-1139. (Pubitemid 10135821)
21. Alberts DS, Peng YM, Chen HS, et al. Therapeutic synergism of hyperthermia cis-platinum in a mouse tumour model. J Natl Cancer Inst. 1980;65:455-461. (Pubitemid 10087439)
22. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743. (Pubitemid 46606227)
23. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 2000;6:727-731. (Pubitemid 30013648)
24. Piso P, Bektas H, Werner U, et al. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol. 2001;27:286-290. (Pubitemid 32621755)
25. McQuellon RP, Loggie BW, Lehman AB, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2003;10:155-162. (Pubitemid 40485936)
26. Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon's role. Langenbecks Arch Surg. 1999;384:576-587. (Pubitemid 30020346)
27. Sugarbaker PH. Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer. In: Sugarbaker P, ed. Peritoneal carcinomatosis: drugs and diseases. Boston: Kluwer Academic Publishers; 1996:75-86.
28. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29-42.
29. Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49-58. (Pubitemid 26130826)
30. Sarnaik AA, Sussman JJ, Ahmad SA, et al. Technology for the delivery of hyperthermic intraoperative intraperitoneal chemotherapy: a survey of techniques. Recent Results Cancer Res. 2007;169:75-82.